Jarret Glasscock is a geneticist and computational biologist leading the team at Cofactor Genomics, a company pioneering the use of multidimensional RNA models in diagnostics. Dr. Glasscock’s work spans from earliest uses of next-gen RNA-seq data, to the first published cancer genome, and he has been covered in GEN, Wired, and Nature.
Dr. David Messina has spent the last 20 years working in computational biology and genetics. He worked on the Human Genome Project at Washington University in Saint Louis, mapped disease genes at the University of Chicago, and earned his PhD in computational biology in Stockholm, Sweden. As COO at Cofactor Genomics, he oversees daily operations and leads regulatory strategy.
Chief Operating Officer at Cofactor Genomics
View more >>
Natalie first joined Cofactor Genomics in 2013, with a PhD in Chemistry from Washington University in St. Louis. Natalie has developed customized experimental solutions for both DNA and RNA applications at Cofactor, as well as launched and supported diagnostic reference standards as a part of Horizon Discovery’s Diagnostics Division. Natalie now supports Cofactor’s clinical collaborations and outreach efforts as the VP of Market Development, with the goal of expanding the utility of Predictive Immune Modeling for cancer biomarker discovery.
Natalie LaFranzo, PhD
Vice President of Market Development
View more >>